Peptide Bionanomaterials: From Design to Application

Dr Mohamed Elsawy is a Senior Lecturer in Pharmaceutical Sciences at the Leicester School of Pharmacy, De Montfort University and the team leader of the Peptide BioNanomaterials Group (PBNG). He obtained his PhD from School of Pharmacy at Queen's University of Belfast in 2012 followed by a short-term fellowship at University of Bordeaux in 2013 and an EPSRC funded postdoctoral training in University of Manchester between 2014-2017. In 2017, he was appointed a lectureship in Pharmaceutics at the School of Pharmacy and Biomedical Sciences, University of Central Lancashire, then in 2020 he moved to the Leicester Institute for Pharmaceutical Innovation at Leicester School of Pharmacy, where he currently works. Dr Elsawy's research focus on understanding the fundamentals of peptide self-assembly into bio-inspired structures for the design of stable and responsive functional bionanomaterials for various biomedical and pharmaceutical applications, with particular interest in drug delivery and tissue engineering. Together with the rational bottom-up molecular design of peptide nanostructures, his group is currently working towards exploitation of various smart manufacturing technologies for the controlled design and fabrication of these materials.

穆罕默德·艾爾薩維博士是德蒙福特大學萊斯特藥學院藥物科學的高級講師，也是肽生物奈米材料組（PBNG）的團隊負責人。他於2012年在貝爾法斯特女王大學藥學院獲得博士學位，隨後於2013年在波爾多大學進行短期研究獎學金，並於2014年至2017年在曼徹斯特大學接受EPSRC資助的博士後訓練。2017年，他被任命為中央蘭開夏大學藥學與生物醫學科學學院的藥物學講師，然後在2020年轉至萊斯特藥學院的萊斯特藥物創新研究所，目前在此工作。艾爾薩維博士的研究重點在於理解肽自組裝成生物啟發結構的基本原理，以設計穩定且具反應性的功能性生物奈米材料，應用於各種生物醫學和藥物領域，特別關注藥物傳遞和組織工程。與肽奈米結構的理性自下而上的分子設計相結合，他的團隊目前正致力於利用各種智能製造技術，進行這些材料的受控設計和製造。